These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464 [TBL] [Abstract][Full Text] [Related]
24. Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia. Allen SA J Clin Pharmacol; 2000 Nov; 40(11):1296-7. PubMed ID: 11075316 [TBL] [Abstract][Full Text] [Related]
25. [Studies on the pupillary reaction in the course of a psychotropic treatment]. Popkowska N Neurol Neurochir Psychiatr Pol; 1966 Feb; 16(2):167-71. PubMed ID: 5913352 [No Abstract] [Full Text] [Related]
26. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients. Raskind MA; Courtney N; Murburg MM; Backus FI; Bokan JA; Ries RK; Dorsa DM; Weitzman RE Biol Psychiatry; 1987 Apr; 22(4):453-62. PubMed ID: 3567260 [TBL] [Abstract][Full Text] [Related]
27. [Depot-neuroleptics in the treatment of schizophrenia]. Schipper JA Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427 [No Abstract] [Full Text] [Related]
29. Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. Le Vann LJ Am J Ment Defic; 1971 May; 75(6):719-23. PubMed ID: 4932179 [No Abstract] [Full Text] [Related]
30. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia. Goodnick PJ; Tong C; Duncavage MB; Meltzer HY Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962 [No Abstract] [Full Text] [Related]
31. Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics. Pacquay M; Brasseur F Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):46-9. PubMed ID: 798190 [TBL] [Abstract][Full Text] [Related]
32. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia]. Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743 [No Abstract] [Full Text] [Related]
33. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms]. Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J Encephale; 1993; 19(1):17-21. PubMed ID: 8275889 [TBL] [Abstract][Full Text] [Related]
34. Chlorpromazine-induced decrease of red cell aggregability. Costa D; Ghiţescu M; Marcu I; Costa E; Pascu I; Vlădescu M; Duţă E Med Interne; 1981; 19(1):83-7. PubMed ID: 7233051 [TBL] [Abstract][Full Text] [Related]
35. Comparative trial of low dose haloperidol and fluphenazine in office patients. Ayd FJ Dis Nerv Syst; 1972 Mar; 33(3):192-5. PubMed ID: 5022455 [No Abstract] [Full Text] [Related]
36. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients. Chouinard G; Serrano PM; Tetreault L Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310 [No Abstract] [Full Text] [Related]
37. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics. Rompel H; Segal H J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086 [TBL] [Abstract][Full Text] [Related]
38. Haloperidol: fifteen years of clinical experience. Ayd FJ Dis Nerv Syst; 1972 Jul; 33(7):459-69. PubMed ID: 4675174 [No Abstract] [Full Text] [Related]
39. On some mechanisms of haloperidol and chlorpromazine effect [proceedings]. Zurabashvilli A; Butchukuri DA Act Nerv Super (Praha); 1976; 18(3):240-1. PubMed ID: 1007872 [No Abstract] [Full Text] [Related]
40. Maintenance treatment of schizophrenia with long-acting fluphenazine. Niturad A; Ciurezu T; Cucu I Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]